Barinthus Biotherapeutics (BRNS) Short Interest Ratio & Short Volume → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free BRNS Stock Alerts $2.50 +0.07 (+2.88%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Barinthus Biotherapeutics Short Interest DataCurrent Short Volume14,100 sharesPrevious Short Volume10,100 sharesChange Vs. Previous Month+39.60%Dollar Volume Sold Short$37,252.20Short Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares38,920,000 sharesFloat Size35,700,000 sharesShort Percent of Float0.04%Today's Trading Volume6,800 sharesAverage Trading Volume19,054 sharesToday's Volume Vs. Average36% Short Selling Barinthus Biotherapeutics ? Sign up to receive the latest short interest report for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBRNS Short Interest Over TimeBRNS Days to Cover Over TimeBRNS Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Barinthus Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202414,100 shares $37,252.20 +39.6%0.0%0.6 $2.64 3/31/202410,100 shares $24,038.00 -15.1%0.0%0.5 $2.38 3/15/202411,900 shares $29,393.00 -3.3%0.0%0.8 $2.47 2/29/202412,300 shares $34,809.00 -12.8%0.0%0.8 $2.83 2/15/202414,100 shares $34,968.00 -55.8%0.0%1.2 $2.48 1/31/202431,900 shares $87,725.00 No Change0.1%1.3 $2.75 BRNS Short Interest - Frequently Asked Questions What is Barinthus Biotherapeutics' current short interest? Short interest is the volume of Barinthus Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 14,100 shares of BRNS short. 0.04% of Barinthus Biotherapeutics' shares are currently sold short. Learn More on Barinthus Biotherapeutics' current short interest. What is a good short interest ratio for Barinthus Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BRNS shares currently have a short interest ratio of 1.0. Learn More on Barinthus Biotherapeutics's short interest ratio. What is a good short interest percentage for Barinthus Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Barinthus Biotherapeutics' floating shares are currently sold short. Is Barinthus Biotherapeutics' short interest increasing or decreasing? Barinthus Biotherapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 14,100 shares, an increase of 39.6% from the previous total of 10,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Barinthus Biotherapeutics' float size? Barinthus Biotherapeutics currently has issued a total of 38,920,000 shares. Some of Barinthus Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Barinthus Biotherapeutics currently has a public float of 35,700,000 shares. How does Barinthus Biotherapeutics' short interest compare to its competitors? 0.04% of Barinthus Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Barinthus Biotherapeutics: Adagene Inc. (0.04%), Connect Biopharma Holdings Limited (0.16%), Kinnate Biopharma Inc. (2.01%), Citius Pharmaceuticals, Inc. (8.29%), NGM Biopharmaceuticals, Inc. (4.52%), Landos Biopharma, Inc. (0.03%), Rallybio Co. (17.17%), Vaxxinity, Inc. (9.31%), Kezar Life Sciences, Inc. (5.25%), Checkpoint Therapeutics, Inc. (12.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Barinthus Biotherapeutics stock? Short selling BRNS is an investing strategy that aims to generate trading profit from Barinthus Biotherapeutics as its price is falling. BRNS shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Barinthus Biotherapeutics? A short squeeze for Barinthus Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BRNS, which in turn drives the price of the stock up even further. How often is Barinthus Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRNS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Clearside Biomedical Short Interest Data Anixa Biosciences Short Interest Data IO Biotech Short Interest Data Oramed Pharmaceuticals Short Interest Data DiaMedica Therapeutics Short Interest Data BioXcel Therapeutics Short Interest Data Cellectar Biosciences Short Interest Data ProPhase Labs Short Interest Data Genelux Short Interest Data Allakos Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BRNS) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace